| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |